List view / Grid view
At the 66th ASMS Conference, Bruker announces innovative mass spectrometry products and workflows for breakthroughs in life-science research, in clinical research and large-cohort validations in phenomics and proteomics, in novel biopharma applications and in applied toxicology and forensics markets...
New research has found biomarkers that accurately identified pregnant women who would go on to deliver babies up to two months prematurely...
Bioengineers may be able to use the unique mechanical properties of diseased cells, such as metastatic cancer cells, to help improve delivery of drug treatments to the targeted cells...
Today, at the 66th Conference on Mass Spectrometry and Allied Topics, Thermo Scientific and Evosep announced a joint effort to develop and promote robust, high-throughput workflows for clinical proteomics...
OPTEL GROUP, a leading global provider of traceability systems for diverse industries, namely for pharmaceuticals, medical devices, healthcare, food and natural resources, announced today that it will be exhibiting an entirely serialised line at this year’s edition of Achema, from 11 - 15 June 2018, in Frankfurt, Germany, at Stand F31…
The EMA has recommended granting a marketing authorisation for Tegsedi, a medicine for the treatment of stage 1 or stage 2 polyneuropathy...
Therapix Biosciences Ltd, have announced that the first subject was enrolled for its Phase IIa, a sponsor-initiated clinical trial for Obstructive Sleep Apnea...
A group of researchers have completed a phase II study comparing a set of DNA markers to alpha-fetoprotein as a method to test for liver cancer....
Acidosis related to use of metformin seen only in those with severely decreased kidney function...
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments.
A novel PET imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease...
The U.S. Food and Drug Administration has approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta to help reduce the risk of infection during cancer treatment.
Once-daily oral pill could replace preoperative chemotherapy in patient population if validated in larger trials...
Scientists have developed a new way of seeing when heavy wound scars are forming and providing doctors with the chance to intervene...
Researchers have developed a new form of microscopy that allows them to observe the formation and evolution of cell membrane focal adhesions...
